Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, WuXi Biologics (WXXWY) has a market cap of $11.02 billion USD. According to our data, WuXi Biologics is ranked No.1491 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $11.02 B |
21.54%
|
| Dec 31, 2024 | $9.07 B |
-40.56%
|
| Dec 29, 2023 | $15.26 B |
-50.56%
|
| Dec 30, 2022 | $30.87 B |
-35.71%
|
| Dec 31, 2021 | $48.01 B |
-10.91%
|
| Dec 31, 2020 | $53.89 B |
211.62%
|
| Dec 31, 2019 | $17.29 B |
101.84%
|
| Dec 31, 2018 | $8.57 B |
11.55%
|
| Dec 29, 2017 | $7.68 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Samsung Biologics
207940.KS
|
$51.32 B |
-0.149 B
|
S. Korea
|
 Catalent
CTLT
|
$11.52 B |
0.000 M
|
USA
|
 Charles River Laboratories
CRL
|
$5.20 B |
-0.000 M
|
USA
|
 Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
USA
|
 ICON plc
ICLR
|
$11.73 B |
0.000 M
|
Ireland
|
 BioNTech
BNTX
|
$23.80 B |
0.001 M
|
Germany
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
| Market Cap | = | WXXWY Stock Price | * | WXXWY Shares Outstanding |
| = | $5.41 | * | 2.02 B | |
| = | $11.02 B |